Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks

Published:2016-06-21 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Blankenbach Kira V.,Schwalm Stephanie,Pfeilschifter Josef,Meyer zu Heringdorf Dagmar

Funder

Deutsche Forschungsgemeinschaft

Fondation Leducq

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference163 articles.

1. Sphingosine-1-phosphate receptor 2.;Adada;FEBS J.,2013

2. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion.;Adada;FASEB J.,2015

3. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.;Ader;Oncotarget,2015

4. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.;Adyshev;Cell. Signal.,2011

5. Truth and consequences of sphingosine-1-phosphate lyase.;Aguilar;Adv. Biol. Regul.,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of the molecular link: STAT3 is a shared key gene linking postmenopausal osteoporosis and sarcopenia;Bone & Joint Research;2024-08-28

2. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis;Pharmaceutics;2024-02-06

3. Progressive Disruption of Sphingosine-1-Phosphate Receptor 1 Correlates with Blood-Brain Barrier Leakage in A Rat Model of Chronic Hypoxic Hypoperfusion;aging and disease;2024

4. Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 Treatment;Diabetes;2023-08-25

5. Chronic Glucocorticoid Exposure Induced an S1PR2-RORγ Axis to Enhance Hepatic Gluconeogenesis in Male Mice;Diabetes;2023-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3